Introduction
The choice between asset and stock deal structure is one of the first decisions in any M&A transaction, and in healthcare, the analysis involves considerations that have no equivalent in other sectors. The general M&A principle that buyers prefer asset deals (for the stepped-up tax basis) and sellers prefer stock deals (for capital gains treatment) still applies, but healthcare-specific regulatory considerations often override the tax analysis and push the transaction toward a stock structure.
Why Healthcare Pushes Toward Stock Deals
Healthcare companies hold multiple regulatory authorizations that are tied to the legal entity, not to the physical assets or the business operations. In a stock deal, the legal entity continues to exist (only the ownership changes), so these authorizations remain in place. In an asset deal, the legal entity's assets are sold to a new entity, and the regulatory authorizations may need to be re-obtained by the buyer.
- Medicare Provider Number
A unique identifier assigned by CMS that allows a healthcare entity (hospital, physician practice, home health agency, skilled nursing facility) to bill and receive reimbursement from Medicare. The provider number is tied to the legal entity and the enrolled location. In a stock deal, the provider number typically remains intact because the legal entity continues. In an asset deal, the buyer must obtain a new provider number through the CMS enrollment process, which can take 60-120+ days. During this gap, the buyer cannot bill Medicare, creating a revenue interruption that can be devastating for healthcare businesses where Medicare represents 30-50%+ of revenue.
| Regulatory Asset | Stock Deal Impact | Asset Deal Impact |
|---|---|---|
| Medicare provider number | Remains with entity | Must re-enroll (60-120+ days) |
| State licenses | Remain (ownership change notice) | Must re-apply (30-180 days) |
| DEA registration | Remains (ownership change filing) | Must re-register (4-8 weeks) |
| Certificate of Need | Remains with entity | Must transfer or re-apply (months to years) |
| Payer contracts | Change-of-control provisions apply | Anti-assignment clauses apply |
| Accreditation | Remains (ownership notice required) | May need new accreditation survey |
When Asset Deals Still Make Sense in Healthcare
Despite the regulatory friction, asset deals remain appropriate in several healthcare scenarios.
Cherry-picking assets. When the buyer wants specific locations, service lines, or provider relationships but not the entire entity. This is common in healthcare services add-on acquisitions where a PE platform acquires specific clinic locations from a larger competitor.
Avoiding successor liability. Asset deals generally protect the buyer from the seller's pre-closing liabilities. In healthcare, where fraud and abuse exposure can create substantial successor liability, asset deals provide a cleaner separation (though not complete immunity, as certain healthcare liabilities can follow the assets).
Tax-exempt sellers. When the seller is a tax-exempt entity (nonprofit hospital, health system), the asset-vs-stock tax analysis differs because the seller does not benefit from capital gains treatment.
The next article covers fraud and abuse law exposure in healthcare transactions, including the interlocking risks of the Anti-Kickback Statute, Stark Law, and False Claims Act.
Free Interview PDF Guide